REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ), Blue Cross Blue Shield of Arizona, Blue Cross of Idaho and Blue Cross Blue Shield of Kansas City have each issued a positive medical policy for the HeartFlow® FFRct Analysis, a first-of-its-kind noninvasive technology […]
Author: Ken Dropiewski
Penumbra, Inc. Reports Second Quarter 2017 Financial Results
ALAMEDA, Calif., Aug. 8, 2017 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on interventional therapies, today reported financial results for the second quarter ended June 30, 2017. Revenue of $80.6 million in the second quarter of 2017, an increase of 23.8%, or 24.6% in constant currency1, over the second quarter of 2016. […]
Researchers receive $1.5 million each to study extracellular matrix for cardiovascular research
DALLAS, Aug. 9, 2017 /PRNewswire/ — Two researchers have been awarded grants that could help uncover the next breakthrough in heart-health research, the American Heart Association and The Paul G. Allen Frontiers Group announced Wednesday. Suneel Apte at the Cleveland Clinic and Jeffrey Holmes at the University of Virginia have been awarded $1.5 million each to study the extracellular matrix […]
Bard Shareholders Approve Proposed Merger With Becton, Dickinson
MURRAY HILL, N.J. and FRANKLIN LAKES, N.J., Aug. 8, 2017 /PRNewswire/ — C. R. Bard, Inc. (NYSE: BCR) (“Bard”) and Becton, Dickinson and Company (NYSE: BDX) (“BD”) today announced the results of Bard’s special meeting of shareholders, held on August 8, 2017 and at which a quorum was present, for Bard shareholders to consider and vote upon the proposed […]
Corindus Vascular Robotics Reports Second Quarter 2017 Results
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for the quarter ended June 30, 2017. Recent Highlights and Accomplishments Revenue of $2.3 million in the second quarter 2017 Increased CorPath® GRX installed base to 16 systems with three new […]
Notice of REVA Medical Briefing Call
SAN DIEGO, Aug. 07, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold a briefing call on Thursday, August 10, 2017 at 4:00 p.m. PDT (which is 9:00 a.m. AEST on Friday, 11 August 2017). Ms. Reggie Groves, the Company’s Chief Executive Officer, will host […]
AUM CARDIOVASCULAR RECEIVES FDA CLEARANCE FOR REVOLUTIONARY DIAGNOSTIC HEART DEVICE
NORTHFIELD, MINNESOTA— AUM Cardiovascular announced that it has received clearance from the Food and Drug Administration for CADence,™ a non-invasive acoustic and ECG device designed to help physicians detect physiological and pathological heart murmurs. The reusable, non-invasive, radiation-free handheld device, which is now available in the United States, records sounds […]
Canon Virginia, Inc. Collaborates with CVR Medical to Manufacture Intuitive, Next-Generation Stroke Prevention Technology
NEWS PROVIDED BY Canon U.S.A., Inc. 10:18 ET NEWPORT NEWS, Va., Aug. 7, 2017 /PRNewswire/ — After recently extending its full range of services to include medical device contract manufacturing and receiving ISO 13485 certification, Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon U.S.A., Inc., announces an intent to collaborate with CVR Global […]
Good News For Baseball Pitchers, Other Athletes
CHICAGO, Aug. 7, 2017 /PRNewswire-USNewswire/ — A national study has confirmed the safety of decompression surgery for thoracic outlet syndrome, also known as TOS. It’s good news for patients whose vascular surgeon has recommended surgery. Thoracic outlet syndrome is relatively rare, but is more common among workers and high performance athletes who […]
CeloNova BioSciences Announces Financing Arrangement with Congruent Investment Partners and SWK Holdings Corporation
CeloNova BioSciences Announces Financing Arrangement with Congruent Investment Partners and SWK Holdings Corporation Proceeds to Support Company Growth, Ongoing Clinical Trial Enrollment and New Product Initiatives CeloNova BioSciences, Inc. (CeloNova), a medical device company that develops, manufactures and markets a family of innovative cardiovascular products based upon its novel Polyzene™-F […]



